Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
307.90
+23.02 (8.08%)
Oct 14, 2025, 4:00 PM EDT - Market closed

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
United States Revenue
1.04B1.04B
Log In
Log In
Log In
Upgrade
EMEA Revenue
844.40M834.10M
Log In
Log In
Log In
Upgrade
APAC Revenue
503.70M521.60M
Log In
Log In
Log In
Upgrade
Other Regional Revenue
163.10M169.30M
Log In
Log In
Log In
Upgrade
Revenue (Other)
4.00K-
Log In
Log In
Log In
Upgrade
Revenue (Total)
2.55B2.57B
Log In
Log In
Log In
Upgrade

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
Life Science Revenue
1.03B1.03B
Log In
Log In
Log In
Upgrade
Clinical Diagnostics Revenue
1.53B1.54B
Log In
Log In
Log In
Upgrade
Other Segments Revenue
-500.00K
Log In
Log In
Log In
Upgrade
Revenue (Other)
4.00K-
Log In
Log In
Log In
Upgrade
Revenue (Total)
2.55B2.57B
Log In
Log In
Log In
Upgrade

Gross Profit

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
Life Science Segment Profit
-582.40M
Log In
Log In
Log In
Upgrade
Clinical Diagnostics Segment Profit
-796.60M
Log In
Log In
Log In
Upgrade
Other Segments Segment Profit
--100.00K
Log In
Log In
Log In
Upgrade
Gross Profit (Other)
1.35B-
Log In
Log In
Log In
Upgrade
Gross Profit (Total)
1.35B1.38B
Log In
Log In
Log In
Upgrade

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
Life Science Operating Profit
--
Log In
Log In
Log In
Upgrade
Clinical Diagnostics Operating Profit
--
Log In
Log In
Log In
Upgrade
Other Segments Operating Profit
--
Log In
Log In
Log In
Upgrade
Operating Income (Other)
223.60M269.00M
Log In
Log In
Log In
Upgrade
Operating Income (Total)
223.60M269.00M
Log In
Log In
Log In
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai.